How Is Fatty Liver Treated? Diet, Drugs, and More

Fatty liver is treated primarily through lifestyle changes, with weight loss being the single most effective intervention. Losing just 5% of your body weight can measurably reduce the amount of fat stored in your liver. For more advanced cases where inflammation and scarring are already present, medications and surgical options may also be part of the plan. The specific treatment depends on whether your fatty liver is caused by alcohol, by metabolic factors like obesity and diabetes, or both.

Weight Loss Is the Most Effective Treatment

No medication matches what sustained weight loss can do for a fatty liver. A 5% reduction in body weight has been shown to improve liver fat levels, and losing more brings greater benefits. Reaching 7% to 10% loss can resolve the inflammation seen in the more serious form of the disease (called steatohepatitis) and even begin to reverse scarring.

The challenge is that people with fatty liver often have a harder time losing weight and keeping it off. Insulin resistance, which is common in this condition, makes the body more efficient at storing fat and more resistant to releasing it. That doesn’t mean weight loss is impossible, but it does mean realistic, gradual goals matter more than aggressive short-term diets.

What to Eat (and What to Cut)

A Mediterranean-style eating pattern has the strongest clinical evidence behind it for fatty liver. This means building meals around vegetables, whole grains, legumes, fish, nuts, and olive oil while keeping red meat, added sugars, and processed foods to a minimum. In clinical trials, the macronutrient breakdown that showed benefit was roughly 40% to 50% of calories from carbohydrates, 15% to 25% from protein (with an emphasis on plant-based sources), and 30% to 40% from fat, mostly unsaturated.

Calorie reduction matters too. Studies testing the Mediterranean diet for fatty liver typically paired it with a moderate calorie deficit, often around 1,400 to 1,600 calories per day or a 30% reduction from what participants were eating before. You don’t need to count every calorie precisely, but eating less overall, not just eating differently, is part of the equation.

Two specific items deserve attention. Fructose, especially from sugary drinks and processed foods, is particularly harmful to the liver because it’s metabolized almost entirely there and readily converted to fat. Cutting out sodas, fruit juices, and foods with added sugars can make a noticeable difference quickly. Alcohol, even in moderate amounts, adds additional stress to an already burdened liver and is best minimized or eliminated entirely.

How Exercise Helps Beyond Weight Loss

Exercise reduces liver fat even when the number on the scale doesn’t change much. Both aerobic exercise and strength training have demonstrated benefits, and combining the two appears to work best.

For aerobic exercise, the equivalent of about 12 miles of walking or jogging per week at a moderate-to-vigorous pace (roughly 150 to 200 minutes per week) is the level shown to reduce liver and visceral fat in clinical studies. For strength training, three sessions per week covering eight or so exercises at 3 sets of 8 to 12 repetitions each produced measurable improvements in liver enzymes and insulin resistance.

If that sounds like a lot, starting smaller still helps. Even 30 minutes of brisk walking most days of the week is a meaningful step. The key is consistency over intensity.

When Alcohol Is the Cause

If your fatty liver is related to drinking, the treatment is straightforward but not easy: stop or dramatically reduce alcohol consumption. The liver responds to abstinence faster than many people expect. Research shows that two to four weeks without alcohol can reduce liver inflammation and begin to normalize elevated liver enzymes in heavy drinkers. Partial healing of the liver can begin within two to three weeks, though the full timeline depends on how long and how much you’ve been drinking.

Alcohol-related fatty liver that hasn’t progressed to severe scarring is one of the most reversible forms of liver disease. But continuing to drink, even at lower levels, keeps the liver under stress and allows the damage to progress.

The First FDA-Approved Medication

For decades, there were no medications specifically approved for fatty liver disease. That changed in 2024 when the FDA approved a drug called Rezdiffra (resmetirom), the first medication specifically targeting the condition.

Rezdiffra works by activating a thyroid hormone receptor that’s concentrated in the liver. This receptor helps the liver process and clear out stored fat (triglycerides) without significantly affecting thyroid hormone activity in the heart or bones. In clinical trials, the drug improved both liver inflammation and scarring.

It’s not for everyone, though. Rezdiffra is approved only for adults who have the inflammatory form of fatty liver disease (steatohepatitis) with moderate to advanced scarring but who haven’t yet reached cirrhosis. It’s meant to be used alongside diet and exercise, not as a replacement. European guidelines similarly recommend considering it for patients with significant fibrosis (stage 2 or higher) when locally approved. No medication targeting fatty liver disease is currently recommended for people who already have cirrhosis.

Other Medications Your Doctor May Discuss

Before Rezdiffra’s approval, two off-label options were commonly used based on trial evidence. Vitamin E at 800 IU daily showed benefit in people with steatohepatitis who don’t have diabetes. A diabetes medication called pioglitazone, taken at 30 mg daily, also reduced liver inflammation in a landmark trial that ran for nearly two years. Both carry their own risks and aren’t appropriate for every patient, so they tend to be reserved for specific situations.

A newer class of medications originally developed for diabetes and weight loss is generating significant interest. These drugs, which mimic gut hormones involved in appetite and blood sugar regulation, are being tested in large clinical trials for fatty liver disease. A major phase III trial is studying weekly injections of semaglutide (the active ingredient in Ozempic and Wegovy) in over 800 patients with fatty liver and fibrosis, with results expected over several years of follow-up. A phase II trial of tirzepatide (the active ingredient in Mounjaro and Zepbound) at various doses showed promising results at one year. Neither is approved specifically for fatty liver yet, but their ability to produce substantial weight loss makes them relevant to the conversation.

Bariatric Surgery for Severe Cases

For people with obesity who haven’t achieved sufficient weight loss through diet, exercise, and medication, bariatric surgery is a recognized treatment option. Current European clinical guidelines include it as part of the management strategy for fatty liver in people with obesity. The dramatic and sustained weight loss that follows surgery often resolves liver fat, inflammation, and even moderate scarring. It’s not a first-line approach, but for the right candidate, it can be transformative.

How Doctors Assess Your Liver’s Condition

Treatment decisions depend heavily on how much damage has already occurred, particularly whether scarring (fibrosis) is present. Your doctor can estimate this without a biopsy using a simple blood test calculation called a FIB-4 score, which combines your age, platelet count, and two liver enzymes.

For people 65 and younger, a score below 1.3 suggests advanced fibrosis is unlikely, and the condition can typically be managed with lifestyle changes in primary care. A score above 3.25 indicates a higher likelihood of significant scarring and usually triggers a referral to a liver specialist. Scores between those numbers fall into a gray zone that requires additional testing, such as an imaging-based scan that measures liver stiffness. For people over 65, the lower cutoff is raised to 2.0 because age itself elevates the score.

About 10% of people aged 45 to 74 who are screened have FIB-4 values above 3.25 and are candidates for specialist referral. Screening is particularly important if you have type 2 diabetes, obesity with additional metabolic risk factors, persistently abnormal liver enzymes, or signs of fat on an abdominal ultrasound.

What Happens if Fatty Liver Progresses

Most people with simple fatty liver (fat without inflammation) will never develop serious liver problems, especially if they make lifestyle changes. But a subset progresses to steatohepatitis, where inflammation begins damaging liver cells. Over years or decades, this can lead to fibrosis, then cirrhosis, and in some cases liver cancer.

Managing advanced disease looks different from early-stage treatment. People with cirrhosis need regular monitoring for complications like portal hypertension (high blood pressure in the liver’s blood vessels) and liver cancer screening. Nutritional counseling becomes more specialized because cirrhosis changes how the body processes nutrients and medications. In cases of decompensated cirrhosis, where the liver can no longer perform its essential functions adequately, liver transplantation may be the only remaining option.

The encouraging reality is that fatty liver caught at an early stage is highly reversible. The liver has a remarkable capacity to heal when the underlying causes, whether excess weight, poor diet, inactivity, or alcohol, are addressed consistently over time.